CAPELLI, Irene
 Distribuzione geografica
Continente #
NA - Nord America 537
AS - Asia 294
EU - Europa 258
SA - Sud America 9
Totale 1.098
Nazione #
US - Stati Uniti d'America 515
BD - Bangladesh 239
IT - Italia 236
SG - Singapore 29
CA - Canada 10
CN - Cina 9
DE - Germania 7
BR - Brasile 6
JM - Giamaica 6
GB - Regno Unito 4
JP - Giappone 4
FI - Finlandia 3
HK - Hong Kong 3
IN - India 3
MX - Messico 3
VN - Vietnam 3
CO - Colombia 2
ID - Indonesia 2
PT - Portogallo 2
AR - Argentina 1
CR - Costa Rica 1
FR - Francia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LU - Lussemburgo 1
NL - Olanda 1
PK - Pakistan 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 1.098
Città #
Ashburn 158
San Jose 106
New York 65
Milan 60
Miano 18
Buffalo 15
Rome 15
Singapore 15
Los Angeles 13
Santa Clara 10
Bologna 9
Naples 9
Chicago 7
Dallas 6
Fairfield 5
Kingston 5
Bari 4
Florence 4
London 4
Pasadena 4
Toronto 4
Turin 4
Atlanta 3
Beijing 3
Hong Kong 3
Houston 3
Munich 3
Philadelphia 3
Phoenix 3
Tokyo 3
Brescia 2
Brooklyn 2
Charlotte 2
Concesio 2
Denver 2
Des Moines 2
Genoa 2
Kansas City 2
Mexico City 2
Milwaukee 2
Modena 2
Montreal 2
Padua 2
Pescara 2
Pittsburgh 2
Queens 2
Seattle 2
Tivoli 2
Woodbridge 2
Albany 1
Anaheim 1
Ann Arbor 1
Arcevia 1
Arezzo 1
Atlantic Highlands 1
Austin 1
Baraboo 1
Belpasso 1
Bergamo 1
Boca Raton 1
Boerne 1
Bogotá 1
Cartago 1
Catania 1
Chennai 1
Chester 1
Chino 1
Cincinnati 1
Columbia 1
Columbia City 1
Concord 1
Davis 1
Durazzano 1
Düsseldorf 1
East Jakarta 1
Elgin 1
Elkton 1
Evanston 1
Falls Church 1
Fresno 1
Giffone 1
Grand Rapids 1
Greeley 1
Greenwood 1
Guatemala City 1
Hamburg 1
Hanoi 1
Havertown 1
Helsinki 1
Hempstead 1
Ho Chi Minh City 1
Igarapé-Miri 1
Jackson 1
Jakarta 1
Jefferson 1
Juneau 1
Katy 1
Lafayette 1
Lappeenranta 1
Lauterbourg 1
Totale 653
Nome #
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 143
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progression 29
Kidney transplant in fabry disease: A revision of the literature 25
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights 24
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 23
Low-Level Mosaicism in Tuberous Sclerosis Complex (TSC): Diagnostic and Clinical Implications From Two Novel Cases and Literature Review 22
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients 20
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 19
Trapianto renale nelle malattie da errori congeniti del metabolismo = Kidney Transplantation and inborn errors of metabolism 18
Nutritional Vitamin D in CKD: Should We Measure? Should We Treat? 17
Fabry disease: a rare disorder calling for personalized medicine 17
Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy 17
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry disease 15
Neutrophil Gelatinase-Associated Lipocalin Increases HLA-G(+)/FoxP3(+) T-Regulatory Cell Population in an In Vitro Model of PBMC 15
Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? 15
The need for clinical, genetic and radiological characterization of atypical polycystic kidney disease 14
Mineral and Electrolyte Disorders With SGLT2i Therapy 14
DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort 14
No evidence of Fabry disease in a patient with the new p.Met70Val GLA gene variant 13
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 13
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 13
The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease 12
The Role of Kidney Biopsy in Fabry Disease 12
Pediatric Urology: Contemporary Strategies from Fetal Life to Adolescence 12
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients 11
The key role of phosphate on vascular calcification 11
Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of PKD1 Hypomorphic Alleles 11
Optimizing urine albumin-to-creatinine ratio testing and referral pathways for chronic kidney disease: a nominal group technique consensus study among Italian experts 11
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 11
Atrial changes after kidney transplant: what diagnostic and therapeutic perspectives? 11
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 11
A Case Report of Tolvaptan Therapy for ADPKD Patients with COVID-19. The Need for Appropriate Counselling for Temporary Drug Discontinuation 11
Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease 10
Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white? 10
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 10
The Fabry Nephropathy in Patients with N215S Variant 10
Fabry Disease Nephropathy: Histological Changes With Nonclassical Mutations and Genetic Variants of Unknown Significance 10
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking 9
COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis? 9
Hepatorenal syndrome: Update on diagnosis and treatment 9
Increase in Serum Amylase and Resistive Index After Kidney Transplant Are Biomarkers of Delayed Graft Function 9
Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families 9
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 9
Fifteen-year analysis of deceased kidney donation: A single transplant center experience in a region of northern Italy 9
Medullary sponge kidney: unusual finding in kidney transplant recipient 9
Integrated use of Autosomal Dominant Polycystic Kidney Disease Prediction Tools and Risk Prognostication 9
Clinical Relevance of IFT140 Loss-of-Function Variants in Development of Renal Cysts 9
Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants 9
MR Brain Screening in ADPKD Patients 9
Removal of free light chains in hemodialysis patients without multiple myeloma: A crossover comparison of three different dialyzers 9
New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure 9
Importance of vascular calcification in kidney transplant recipients 9
Primary hyperoxaluria type 1 diagnosis in adult dialysis patients: prediction model assessment in a group of Italian patients 9
Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature 9
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation 8
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 8
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 8
Serum and Urinary Neutrophil Gelatinase-associated Lipocalin Monitoring in Normal Pregnancy Versus Pregnancies Complicated by Pre-eclampsia 8
Low protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay and mortality 8
Fibroblast Growth Factor 23: Mineral Metabolism and beyond 8
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin 8
Vitamin D effects on bone homeostasis and cardiovascular system in patients with chronic kidney disease and renal transplant recipients 8
The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes 8
Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients 8
Folic Acid and Vitamin B12 Administration in CKD, Why Not? 8
Vitamin B supplementation and nutritional intake of methyl donors in patients with chronic kidney disease: A critical review of the impact on epigenetic machinery 8
Effect of Vitamin D Receptor Activator Therapy on Vitamin D Receptor and Osteocalcin Expression in Circulating Endothelial Progenitor Cells of Hemodialysis Patients 8
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 8
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease 8
Coupled Plasma Filtration Adsorption Application for Liver and Thyroid Toxins 8
Urinary neutrophil gelatinase-associated lipocalin at birth predicts early renal function in very low birth weight infants 8
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis 8
Extreme placement of a tunneled cuffed catheter for hemodialysis 8
When native arteriovenous fistula is not possible: the permanent catheter is better 8
Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective 8
SGLT2 inhibitors, sodium and off-target effects: an overview 7
Functional and histopathologic correlation in the fabry nephropathy with N215S genotype 7
Potential advantages of acute kidney injury management by mesenchymal stem cells 7
Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients 7
Predictive model for delayed graft function based on easily available pre-renal transplant variables 7
Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells 7
Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants 7
Vitamin D-FGF-23 axis in kidney transplant recipients 7
Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study 7
Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: A retrospective study 7
The role of activin: The other side of chronic kidney disease-mineral bone disorder? 7
Coexistence of Alport Syndrome and Fabry Disease in a Female with R112H Variant: Early Progression of Fabry Nephropathy 7
The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function 6
Combined plasmatic and tissue approach to membranous nephropathy - Proposal of a diagnostic algorithm including immunogold labelling: Changing the paradigm of a serum-based approach 6
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 6
Genetics and Autosomal Dominant Polycystic Kidney Disease Progression 6
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights 6
Alpine skiing and anaerobic performance in solid organ transplant recipients 6
Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients 6
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 6
Seroprevalence of a “new” bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients 6
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival 6
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 6
Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy 6
Impact of the Type of Dialysis on Time to Transplantation: Is It Just a Matter of Immunity? 6
Totale 1.157
Categoria #
all - tutte 5.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 2 0 0 1 0 1 0 0 0 1 3
2022/20236 2 0 0 0 0 0 0 0 0 0 2 2
2023/202411 2 0 2 1 0 0 0 1 0 2 1 2
2024/202532 0 0 3 1 4 4 1 2 9 4 2 2
2025/20261.160 8 0 5 17 14 9 4 8 3 49 742 301
Totale 1.222